2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use

Completed · Not applicable

Conditions studied: Primary Arthrosis, Post Traumatic Arthritis, Rheumatoid Arthritis, Osteoarthritis

In brief

This post-approval study is being conducted to examine the performance of the STAR Ankle under actual conditions of use.

Key facts

Study ID

NCT01284283

Run by

Encore Medical, L.P.

People needed

102

Starts

2009-11-01

Expected to finish

2021-03-01

Last updated by the study team

2022-07-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Moderate or severe pain, loss of mobility and function of the ankle (Buechel-Pappas Scale)
• Primary arthrosis, post traumatic arthrosis or rheumatoid arthrosis
• At least six months of conservative treatment for severe ankle conditions, confirmed by the patient medical history, radiograph studies and medication record
• Willing and able to give informed consent

You may not qualify if…

• Patients who have not reached skeletal maturity
• Active or prior deep infection inthe ankle joint or adjacent bones
• Prior arthrodesis at the involved site
• History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol
• Obesity (weight greater than 250 lbs)
• History of current prior drug abuse or alcoholism
• Any physical condition precluding major surgery
• Hindfoot malpositioned by more than 35 degrees or forefoot malalignment which would preclude a plantigrade foot
• Lower extremity vascular insufficiency demonstrated by Doppler arterial pressure
• Avascular necrosis of the talus
• Inadequate skin coverage above the ankle joint
• Patients under the age of 35 who are unwilling or unable to accept the physical limitations imposed by ankle arthroplasty, including limitations on certain vigorous physical activities (e.g. basketball, football) and on manual labor
• Juvenile onset Type I diabetes
• Adult onset Type II diabetes when accompanied by neuropathic changes or a history of foot infection in either foot
• Pregnancy
• Avascular necrosis of the tibia
• Significant bone tumor of the foot or ankle
• Severe deformity that would not normally be eligible for ankle surgery
• Prior surgery and/or injury that has adversely affected the ankle bone stock
• Severe osteoporotic or osteopenic condition or other conditions that may lead to inadequate implant fixation in the bone
• Insufficient ligament support
• Motor dysfunction due to neuromuscular impairment

Where it is running

• The CORE Institute — Phoenix, Arizona, United States
• Cedars Sinai Medical Center — Los Angeles, California, United States
• Palo Alto Medical Research Foundation (Sutter Health) — Palo Alto, California, United States
• Kaiser Permanente — San Francisco, California, United States
• William Beaumont Hospital — Royal Oak, Michigan, United States
• Reno Orthopaedic Center — Reno, Nevada, United States
• Kenneth Mroczek, MD-NYU — New York, New York, United States
• University of Pennsylvania Health Systems-PA Foot and Ankle Surgeons — Philadelphia, Pennsylvania, United States
• Center for Foot and Ankle Restoration — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.